After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...

Q4 2024 Management View CEO Reshma Kewalramani highlighted the planned leadership transitions, with Stuart Arbuckle retiring in July 2025. Charlie Wagner will take on additional responsibilities as ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...

Community notes are usually accurate but very slow. How realistic is Vitalik Buterin's proposal to speed up the process using ...

Mathematical equations have shaped our understanding of the universe, and these nine have played a key role in changing the world.

From packable sleeping pads to ultracomfortable air beds, we tested and found the best camping mattresses and sleeping pads ...

Jess started her career at TechRadar, covering news and hardware reviews. Meta, Google, TikTok, and X have each pledged to European lawmakers that they will do more to prevent and remove illegal ...

Social network X is trying to capitalize on the uncertainty surrounding ByteDance apps like TikTok and Lemon8 by launching a dedicated vertical video feed. The company is adding a video tab in the ...